No full-text available
To read the full-text of this research,
you can request a copy directly from the authors.
Effects of Horse oil on the DNCB-induced Contact Hypersensitivity in Balb/c Mice
Abstract
Objectives : Horse oil (HO) has been used long time as the folk medicine of many Asian countries such as Korea, Mongol, China, India and Japan. HO has been used for anti-bacterial, anti-inflammatory, and anti-pruritic purposes in skin. However, it is still largely unknown whether HO modulates the skin condition. In this study, we attempted to evaluate the anti-inflammatory effect of HO on the 1 % of 2, 4-dinitro-1-chlorobenzene (DNCB)-induced contact hypersensitivity in Balb/c mice. Methods : To find the anti-inflammatory effect of HO, contact hypersensitivity, a local inflammatory response of skin, was induced on the back of Balb/c mice by sensitization and repeated application by 1% DNCB and HO treated 2 weeks on the 1% of DNCB-treated Balb/c mice. Excised mice skins were stained with hematoxylin and eosin and serum IgE level was measured by mouse IgE ELISA kit. Results : In this study, we found that HO reduced erythema by 1% of DNCB treated Balb/c mice. Also, HO recovered histopathological features such as the thickening of epidermis, hyperkeratosis and the infiltration of inflammatory cells in 1% of DNCB treated Balb/c mice. In addition, HO reduced IgE level on the serum obtained from blood of 1% of DNCB-treated Balb/c mice. Conclusion : Taken together, these results showed that HO could be used as a pharmaceutical material with anti-inflammatory effects by reducing of erythema, IgE level and recovering of histopathological features skin on DNCB-induced contact hypersensitivity in Balb/c mice model.
... Based on traditional Chinese medical books, horse oil has healing effects for burn wounds and skin damage [7][8][9]. Horse oil is comprised of 60%-65% unsaturated fatty acids, its composition is close to that of sebum produced by sebaceous glands in human beings, its composition is close to that of sebum produced by sebaceous glands in human beings, and it is easily absorbed by human skin [10]. Horse oil is reported to produce anti-inflammatory effects by reducing erythema and IgE level and recovering histopathological signs such as thickening of epidermis, hyperkeratosis, and infiltration of inflammatory cells in 2, 4-dinitrochlorobenzene (DNCB)treated BALB/c mice [10]. ...
... Horse oil is comprised of 60%-65% unsaturated fatty acids, its composition is close to that of sebum produced by sebaceous glands in human beings, its composition is close to that of sebum produced by sebaceous glands in human beings, and it is easily absorbed by human skin [10]. Horse oil is reported to produce anti-inflammatory effects by reducing erythema and IgE level and recovering histopathological signs such as thickening of epidermis, hyperkeratosis, and infiltration of inflammatory cells in 2, 4-dinitrochlorobenzene (DNCB)treated BALB/c mice [10]. ...
... DNCB, an electrophilic and cytotoxic benzene derivative, was used to induce stable clinical atopic dermatitis. Skin changes in DNCB-treated mice were Anti-inflammatory effect of horse oil [10]. A previous study reported anti-inflammatory effects of horse oil, which included the alleviation of DNCB-induced histopathological signs such as thickening of the epidermis, hyperkeratosis, and infiltration of inflammatory cells [10]. ...
The present study evaluated the anti-inflammatory effect of horse oil in 2, 4-dinitrochlorobenzene (DNCB)-treated BALB/c mice. After the application of DNCB, the mice showed atopic dermatitis symptoms, including severe erythema, hemorrhage, and erosion, whereas those symptoms were alleviated by treatment with horse oil. To explain the anti-dermatitis effect of horse oil, the gene expression levels in the healing process in dorsal skin were observed using a cDNA microarray. The cDNA microarray analysis revealed that the expression levels of 30 genes related to the inflammation, including Ccr1, Ccr2, Ccl20, Anxa1, and Hc genes, were up-regulated (higher than 2.0-fold) in the DNCB group compared to the levels in the control group, whereas the levels were restored to the control level in the DNCB + horse oil-treated group. In contrast, the gene expression levels of 28 genes related to inflammation, including chemokine genes Ccl5, Ccl7, Ccl8, Cxcl10, and Cxcl13 genes, were down-regulated (lower than 0.5-fold) in the DNCB group compared to the levels in the control group, whereas the levels were restored to the control level in the DNCB + horse oil-treated group. Overall, the results show that horse oil restores the expression levels of genes related to inflammation that were perturbed by DNCB treatment.
... Horse oil is a popular folk ingredient used in the cosmetic industry among Asian countries. It is claimed that horse oil has antibacterial, anti-inflammatory and antipruritic actions on the skin [38]. A Korean study (with English abstract) demonstrated the anti-inflammatory effect of horse oil in reducing erythema and IgE level of DNCB-induced contact hypersensitivity in Balb/c mice [38]. ...
... It is claimed that horse oil has antibacterial, anti-inflammatory and antipruritic actions on the skin [38]. A Korean study (with English abstract) demonstrated the anti-inflammatory effect of horse oil in reducing erythema and IgE level of DNCB-induced contact hypersensitivity in Balb/c mice [38]. Nonetheless, most studies related to the effects of horse oil are only available in Japanese or Korean with no English translations provided, posing difficulties for dermatologists in the field to evaluate and share the results. ...
Aim
To review current classes of emollients in the market, their clinical efficacy in atopic dermatitis (AD) and considerations for choice of an emollient.
Methods
PubMed Clinical Queries under Clinical Study Categories (with Category limited to Therapy and Scope limited to Narrow) and Systematic Reviews were used as the search engine. Keywords of ‘emollient or moisturizer’ and ‘atopic dermatitis’ were used.
Overview of findings
Using the keywords of ‘emollient’ and ‘atopic dermatitis’, there were 105 and 36 hits under Clinical Study Categories (with Category limited to Therapy and Scope limited to Narrow) and Systematic Reviews, respectively. Plant-derived products, animal products and special ingredients were discussed. Selected proprietary products were tabulated.
Conclusions
A number of proprietary emollients have undergone trials with clinical data available on PubMed-indexed journals. Most moisturizers showed some beneficial effects, but there was generally no evidence that one moisturizer is superior to another. Choosing an appropriate emollient for AD patients would improve acceptability and adherence for emollient treatment. Physician’s recommendation is the primary consideration for patients when selecting a moisturizer/emollient; therefore, doctors should provide evidence-based information about these emollients.
... Dầu ngựa (horse oil) được làm bằng cách chiết xuất dầu từ mỡ ngựa, và là một thành phần dân gian phổ biến được sử dụng trong ngành công nghiệp mỹ phẩm ở các nước châu Á. Dầu ngựa được chứng minh có tác dụng kháng khuẩn, chống viêm và chống ngứa trên da [5]. ...
Nghiên cứu được thực hiện nhằm đánh giá tác dụng làm liền vết bỏng của thuốc mỡ NCB trên chuột cống gây bỏng nhiệt. Chuột được chia thành 3 lô, mỗi lô 8 con, gây bỏng bằng dụng cụ gây bỏng nhiệt. Lô 1 đắp gạc nước muối sinh lý, Lô 2 bôi thuốc Silvirin, lô 3 bôi thuốc NCB, thay băng vết bỏng hàng ngày. Kết quả: Theo dõi trong 28 ngày cho thấy thuốc mỡ NCB có tác dụng giảm viêm nề, giảm tiết dịch mủ, đẩy nhanh quá trình biểu mô hoá, giúp tạo tổ chức hạt đẹp, đẩy nhanh quá trình thu hẹp diện tích vết bỏng, cải thiện chất lượng vết sẹo bỏng tương đương so với thuốc tham chiếu Silvirin. Kết luận: Thuốc mỡ NCB có hiệu quả tốt làm liền vết bỏng do nhiệt trên chuột cống.
... In addition, Camellia japonica seed oil is known to have a dietary effect by reducing low-density lipoprotein cholesterol level and increasing high-density lipoprotein cholesterol level (24). HF could be used as cosmetic and pharmaceutical materials with anti-infl ammatory effects by reducing of erythema and Immunoglobulin E level and recovering of histopathological features of skin (25). In the present study, to determine the required HLB value of essential oils, the method of Orafi diya and Oladimeji was used in which stable emulsions were based on minimum droplet size and maximum turbidity (1). ...
In the present study, the required hydrophilic lipophilic balance (HLB) values of Citrus unshiu fruit oil (CUFO), Citrus unshiu peel oil (CUPO), horse fat (HF), and Camellia japonica seed oil were determined empirically by preparing oil-in-water (o/w) emulsions. Lipophilic and hydrophilic surfactants were prepared in various ratios in o/w emulsion. The droplet size of the emulsion was measured using a particle size analyzer, and the turbidity was measured using a turbidity meter and a ultraviolet (UV)-vis spectrophotometer. According to the Orafidiya-Oladimeji method, the HLB value of the emulsion having the minimum dispersion ratio, the minimum droplet size, and the maximum turbidity degree was determined as the required HLB value for each essential oil. Based on these methods, the required HLB values of CUFO, CUPO, HF, and Camellia japonica seed oil were determined as 14.75-14.90, 15.35-15.40, 6.30-7.06, and 5.94-6.30, respectively.
... 16) . 아울러 보다 유의성 있는 치료제 개발을 위한 실험 연구들이 동물 병태 모델을 이용하여 활발히 진행 된 결과, 현재 수종의 단일 약재 [17][18][19][20] 의 항아토피 효능이 객 관적으로 규명된 바가 있다. ...
Objectives : The aim of this study was to confirm whether or not coral has a preventive effect on development of atopic dermatitis induced by house mite(dermatophagoides pteronyssinus) in NC/Nga mice. Methods : This study was undertaken by using a reliable Atopic dermatitis mouse model demonstrating similar immune response. Lobophytum crassum was administered orally to NC/Nga mouse for 3 weeks. In order to verify the effectiveness of Lobophytum crassum in atopic dermatitis treatment, its role in immune factors were observed in NC/Nga mice. Results : ALT, AST, BUN and creatine levels were all within in the normal ranges in MC-1 200 and 400 (mg/kg) treated groups, indicating no induced toxicity. MC-1 200 and 400 (mg/kg) groups decreased of atopic dermatitis skin manifestation in NC/Nga mouse of MC-1 200 and 400 (mg/kg) groups compared to that of the control group and decreased the ratio of WBC and lymphocyte in blood. Also, MC-1 200 and 400 (mg/kg) groups significant decreased the ratio of CD4+, CD8+, CD11b+/Gr1+, B220/CD23 and CD4/CD25 immune cell ratio in ALN. Finally MC-1 200 and 400 (mg/kg) groups significantly increased the ratio of CD4+, CD8+, B220/CD23 and CD4/CD25 immune cells in DLN. Conclusions : Theses results suggested that Lobophytum crassum has suppressive effects on aberrant and overactive immunological activities in dermatophagoides pteronyssinus-induced dermatitis mice of NC/Nga.
Background:
Cosmeceuticals are commonly used in skincare regimens to maintain healthy skin and improve visible signs of aging. In recent years, South Korean skincare has gained prominence in the global beauty industry by introducing innovative cosmeceutical products and aesthetic trends.
Objectives:
To describe the global impact of Korean skincare and to review the current research evidence for bioactive ingredients commonly found in Korean cosmeceuticals.
Methods:
A review of the biomedical literature was conducted using PubMed to identify laboratory, animal, and clinical studies that evaluated the biological properties and potential dermatologic uses of ingredients found in Korean cosmeceuticals.
Results:
Bioactive ingredients in Korean cosmeceutical products are increasingly undergoing scientific validation and are derived from various sources including animals (eg, bee venom and snail mucin), plants (eg, dragon's blood and tiger grass extract), and biotechnology (eg, synthetic snake venom). Their bioactive components and pharmacologic activities have been shown to provide dermatologic benefits with potential applications for skin rejuvenation, photoprotection, wound healing, and more.
Conclusion:
Further research studies are warranted to elucidate any biological or therapeutic mechanisms of action of these ingredients, which may translate into clinical practice. With the rising public awareness and interest in Korean cosmeceuticals, patients may seek advice from dermatologists about how to incorporate these bioactive ingredients into their skincare regimens to improve skin health and aesthetics.
This study investigated the anti-wrinkle and anti-inflammatory effects of horse bone hydrolysates of <3 kDa (HL) and topically applied horse oil (HO) on UVB-induced photoaging and inflammation in hairless mice. Forty-nine mice were divided into seven groups: −NC, chow without UVB irradiation; +UC, chow with UVB irradiation, +HLL, chow with low dose (500 mg/kg body weight (BW)) HL and UVB irradiation; +HLH, chow with high dose (1000 mg/kg BW) HL and UVB irradiation; +HO, chow and combined with topical application of HO and UVB irradiation; +HOHLL, treated with a combination of dietary HLL and topical application of HO with UVB irradiation; +HOHLH, treated with a combination of dietary HLH and topical application of HO with UVB irradiation. The transepidermal water loss in mice of all treatment groups was lower than that of mice in the +UC group. Furthermore, the wrinkle depth in the +HLH group was significantly lower than that in the +UC group. In addition, HO and low level of HL significantly decreased the level of tumor necrosis factor-α, interleukin-6, and matrix metalloproteinase-9, thereby down-regulating inflammation, including the cyclooxygenase-2 synthesis. In the future, human trials are needed to confirm the efficacy and synergistic effect of HL and HO.
Oxidative stability of horse fat rendered at 70 °C, − 0.1 MPa under vacuum and 110 °C, 0.1 MPa from horse fatty tissues was investigated after the addition of α-tocopherol at 0, 30, 60, and 150 mg/kg during storage at 60 °C in the dark. Peroxide values of initial horse fat rendered at 70 °C under vacuum ranged from 6.10 to 7.40 meq/kg. After 14 days, those of horse fat with α-tocopherol at 0, 30, 60, and 150 mg/kg increased to 142.40, 34.10, 39.37, and 58.23 meq/kg, respectively. Acid values and thiobarbituric acid values of horse fat rendered at 70 °C were lower than those of horse fat at 110 °C. Unsaturated fatty acids contents of horse fat rendered at 70 °C and 110 °C were 58.04 and 57.15%, respectively. These results indicate that rendering at 70 °C under vacuum improved the oxidative stability of horse fat and the addition of α-tocopherol helped to prevent lipid oxidation.
This study was carried out to investigate horse oil qualities which were extracted by hot water by adding various amounts of green tea leaves. To observe the lipid oxidation of various horse oils, factors such as acid value, peroxide value, TBA value, iodine value, and fatty acid composition were evaluated for 49 days. The Ministry of Food and Drug Safety regulations permits edible beef tallow or edible lard to have <0.3 mg KOH/g of acid value and most horse oil complied with the specification of animal fat and oils except for the 0.5% green tea leaves-treated horse oil. The peroxide value and TBA value of all the horse oil were significantly increased during storage but the rate of lipid oxidation was lower in the sample where higher concentration green tea leaves were added. Iodine value was also lower when the amount of green tea leaves was higher in the horse oil extraction processing. In fatty acid composition observation, palmitoleic acid which is a predominantly unsaturated fatty acid in human sebum lipid was increased by adding green tea leaves during extraction processing, but it was decreased for storage. This study would present the basic information of lipid oxidation properties of horse oil and suggest appropriate extraction conditions to inhibit lipid peroxidation by using green tea leaves.
Objectives The aim of this study was to investigate the effects of GalGunSeungGi-Tang (GST) on allergic contact dermatitis (ACD) induced by 2,4-dintrochlorobenzone (DNCB) Methods In this study, The changes of body weight, ear weight, ear thickness, spleen weight, dorsum skin thickness, symptom score by eyesight, histological finding, proliferation rates of splenocyte in vitro and in vivo are investigated to check effects of GST. The mice are divided into four group; Normal (naive mice), Control (DW administered), GST-L (GST 500mg/Kg/day administered), GST-H (GST 1,000mg/Kg/day administered). Results GST inhibited weight of ear significantly (P
Objectives In the theory of Korean Medicine, Cicadae Periostracum (CP) has been used to treat skin diseases such as inflammatory dermatitis, tetanus and pruritus. CP can reduce heat and disperse wind. In prior studies, anti-allergic effect and anti-inflammatory effect of CP were reported. However, there has been no report regarding the correlation of CP and allergic contact dermatitis (ACD). This study was performed to show the effects of CP in ACD induced by 2,4-dinitrochlorobenzene (DNCB) in mice. Methods In this experiment, the effects of CP on biological changes were measured, such as changes in ear and spleen weight, ear and dorsum skin thickness, clinical aspect on the dorsum skin and histological changes. The effect of proliferation rate of splenocytes was also investigated in vitro and vivo study. Results In results, CP application (CPA) group and CP application and administration (CPAA) group were significantly restrained in ear weight gain and increase in ear and dorsum skin thickness compared to the control group. In addition, CPA and CPAA group showed diminished erythema, desquamation, bloodstain, and marks. Also, the histological assessment showed that CP treatement diminished thickness of epidermis, hyperkeratosis, pigmentation and parakeratosis. Conclusions In conclusion, these data suggest that CP can decrease symptoms of ACD.
Atopic dermatitis is characterized by chronically pruritic and inflammatory dermatitis. In this study, we investigated the effect of Platycodon grandiflorum including platycodin D (PG-Platycodin D) in an atopic dermatitis-like mouse model. An atopic dermatitis-like skin lesion was induced by repeated treatment of 2,4-dinitrochlorobenzene (DNCB) on the dorsal skin of ICR mice. The efficacy of PG-Platycodin D was tested by observing scratching behavior, the skin severity score, and histopathologic analysis. PG-Platycodin D reduced the DNCB-induced increase in scratching behavior and the skin severity score. In addition, histopathologic analysis revealed a reduction in the thickening of the epidermis in the PG-Platycodin D group. These results may contribute to the development of a therapeutic drug for the treatment of atopic dermatitis.
Atopic dermatitis (AD) usually develops in patients with an individual or family history of allergic diseases, and is characterized by chronic relapsing inflammation seen especially in childhood, association with IgE hyperproduction and precipitation by environmental factors. However, the exact etiology of AD has been unclear. To further explore the pathogenesis and treatment of AD, a suitable animal model is required. We found that skin lesions, which were clinically and histologically very similar to human AD, spontaneously appeared on the face, neck, ears and dorsal skin of inbred NC/Nga mice when they were raised in non-sterile (conventional) circumstances, but not under specific pathogen-free conditions. Plasma levels of total IgE in conventional NC/Nga mice were markedly elevated from 8 weeks of age, correlating with clinical skin severity of dermatitis. Immunohistochemical examination of the skin lesion showed increased numbers of mast cells and CD4+ T cells containing IL-4 necessary for IgE synthesis. Thus, NC/Nga mice suffered from dermatitis very similar to human AD with IgE hyperproduction, which may be triggered by some environmental factor(s).
Immunoglobulin E (IgE) and mast cells are believed to play important roles in allergic inflammation. However, their contributions to the pathogenesis of human asthma have not been clearly established. Significant progress has been made recently in our understanding of airway inflammation and airway hyperresponsiveness through studies of murine models of asthma and genetically engineered mice. Some of the studies have provided significant insights into the role of IgE and mast cells in the allergic airway response. In these models mice are immunized systemically with soluble protein antigens and then receive an antigen challenge through the airways. Bronchoalveolar lavage fluid from mice with allergic airway inflammation contains significant amounts of IgE. The IgE can capture the antigen presented to the airways and the immune complexes so formed can augment allergic airway response in a high-affinity IgE receptor (FcepsilonRI)-dependent manner. Previously, there were conflicting reports regarding the role of mast cells in murine models of asthma, based on studies of mast cell-deficient mice. More recent studies have suggested that the extent to which mast cells contribute to murine models of asthma depends on the experimental conditions employed to generate the airway response. This conclusion was further supported by studies using FcepsilonRI-deficient mice. Therefore, IgE-dependent activation of mast cells plays an important role in the development of allergic airway inflammation and airway hyperresponsiveness in mice under specific conditions. The murine models used should be of value for testing inhibitors of IgE or mast cells for the development of therapeutic agents for human asthma.
Atopic dermatitis is a chronic inflammatory skin disease associated with cutaneous hyperreactivity to environmental triggers and is often the first step in the atopic march that results in asthma and allergic rhinitis. The clinical phenotype that characterizes atopic dermatitis is the product of interactions between susceptibility genes, the environment, defective skin barrier function, and immunologic responses. This review summarizes recent progress in our understanding of the pathophysiology of atopic dermatitis and the implications for new management strategies.
Experimental drug was applied to a white male mouse taken ill with allergic contact dermatitis to investigate the effects of Yanghyulsamultanggamibang. 1. In case of skin moisture, when it was checked 72 hours later, there showed up meaningful differences among the normal, control, and sample groups. Especially, the moisture increased more noticeably in the sample group than in the control group. 2. With regards to RBC count in blood, it increased more in the control and sample groups than in the normal group when it was checked both in 24 hours and 72 hours. When it was checked in 48 hours, the number of RBC in the sample group increased the most, and the count in the control group increased more than in the normal group. 3. About the neutrophil rate in WBC count, it increased meaningfully more both on the control and sample groups than in the normal group in 24 hours. When the rate was checked in 48 hours, it increased the most in the sample group, and it increased more in the control group than in the normal group. When in checked72 hours later, it increased substantially more in the control group than both the sample and normal group. 4. As of the lymphocyte rate in WBC count, when measured in 24 hours, it increased in the normal group than in the control and sample groups. In 48 hours, it increased the most in the normal group, and it increased meaningfully more in the control group than in the sample group. 5. Regarding the total IgE, when measured 24 hours later, it increased noticeably more in the normal group than in the control and sample groups. In 48 hours, there showed up substantial differences among the normal, control and sample groups. In particular, it increased meaningfully more in the control group than in the sample group. 6. When the sample of skin tissue was examined, the corneal layer restoration increased more in the sample group than in the normal group. The above-mentioned results prove that Yanghyulsamultanggamibang can be taken when allergic contact dermatitis develops on the skin. Long-term observation afterward is also advised.
Objective : This study was performed to investigate the effects of Sophorae Radix and Coptidis Rhizoma-iontophoresis in allergic contact dermatitis. Methods : Contact hypersensitivity assay, video microscope, melanin-erythema levels, pH levels, hydration levels, WBC count, RBC count, neutrophil ratio, lymphocyte ratio and total IgE levels were measured. Results : At contact hypersensitivity assay, the right ear swellings in Sophorae Radix and Coptidis Rhizoma-iontophoresis group were decreased compared with control group, but have no statistical significance. At observation of skin morphologic change, many papules were seen in control group and keratins were seen in Sophorae Radix-iontophoresis group. At melanin levels, Sophorae Radix and Coptidis Rhizoma-iontophoresis groups showed no significant difference compared with control group. At pH levels, Sophorae Radix-iontophoresis group showed significant decreased with control group. At hydration levels, Sophorae Radix and Coptidis Rhizoma-iontophoreses groups showed to significant difference compared with control group. WBC count, RBC count and neutrophil ratio were significantly increased in Sophorae Radix and Coptidis Rhizoma-iontophoresis group compared with control group. Lymphocyte ratio and total IgE levels were significantly decreased in Sophorae Radix and Coptidis Rhizoma-iontophoresis groups compared with control group. At morphology of skin, inflammation was decreased and the thickness of epidermis was well preserved in Sophorae Radix and Coptidis Rhizoma-iontophoresis group. Conclusion : Sophorae Radix and Coptidis Rhizoma-iontophoresis had some anti-allergy, anti-inflammatory effects on allergic contact dermatitis, but had no effects on melanin-erythema levels, pH levels and hydration levels of skin.
The safety and efficacy of 0.03% and 0.1% tacrolimus ointment for the treatment of atopic dermatitis were evaluated in a 12-week, randomized, double-blind, vehicle-controlled study of 351 children 2 to 15 years of age with moderate to severe atopic dermatitis. The mean age of patients was 6.1 years. A total of 61.5% of patients had severe atopic dermatitis at baseline. The mean percentage of body surface area affected was 47.7%, and 83.5% of patients were affected on the head and/or neck. Significantly more patients (P<.001) achieved clinical improvement of 90% or better with 0.03% or 0.1% tacrolimus ointment compared with vehicle. Significant improvements in the signs and symptoms of atopic dermatitis, percent body surface area affected, and the patient's assessment of pruritus were also observed early in treatment and were maintained throughout the study. Adverse events with a statistically significantly greater incidence in the 0.03% tacrolimus ointment treatment group compared with vehicle were limited to the sensation of skin burning, pruritus, varicella, and vesiculobullous rash ("blisters"). Varicella and vesiculobullous rash occurred at a low incidence (<5%). No adverse event occurred at a statistically higher incidence in the 0.1% tacrolimus ointment-treated group compared with vehicle. Tacrolimus ointment was equally safe for younger (2-6 years) and older (7-15 years) children. Both tacrolimus ointment concentrations (0.03% and 0.1%) were safe and significantly more effective than vehicle for the treatment of atopic dermatitis in children.
Atopic dermatitis is a chronic inflammatory skin disease that is frequently associated with respiratory allergies. Atopic dermatitis develops as a result of a complex interrelationship of environmental, immunologic, genetic, and pharmacologic factors. Efforts to understand the relative contributions of these factors have led to research seeking to identify the relevant effector cells and mediators involved in the pathogenesis of atopic dermatitis. These factors include the pattern of local cytokine release, the differentiation of helper T cells, multiple roles of IgE, skin-directed cell responses, infectious agents, and superantigens. This article reviews these cellular and immunologic mechanisms underlying atopic dermatitis and discusses how an understanding of their role in the inflammatory process may lead to improved treatments for atopic dermatitis.
Allergic contact dermatitis (ACD) is a common occupational and environmental health issue. In common with other forms of allergy the disease progresses in two stages; an initial phase during which sensitization is acquired, followed later (after subsequent exposure to the same chemical allergen) by elicitation of a cutaneous inflammatory reaction. The development of skin sensitization is associated with, and requires, the activation and clonal expansion of allergen responsive T lymphocytes and it is these cells that orchestrate the cutaneous allergic reaction. In recent years, much has been learned of the characteristics of immune responses to skin sensitizing chemicals and of the roles played by dendritic cells, cytokines and chemokines. Some of the more interesting cellular and molecular mechanisms are reviewed briefly in this article. A more detailed appreciation of responses induced by chemical allergens has in turn facilitated the design of novel approaches to the toxicological evaluation of skin sensitization. Real progress has been made, not only in the development of improved methods for hazard identification and characterization, but also in the application of new paradigms for risk assessment. The newer methods now available and the opportunities that exist for further advances are considered. Finally, progress has been made in the characterization of skin sensitization in humans and in the clinical management of ACD. This article seeks to consider skin sensitization and ACD in holistic fashion, bridging experimental observations with clinical disease and basic mechanisms with practical toxicology.
The water content of the stratum corneum and skin surface lipids are important factors in the appearance and function of the skin. A disruption of the balance between the two may lead to the clinical manifestation of dryness of skin in patients with atopic dermatitis.
The aim of our study was to examine the so-called dry skin of patients with atopic dermatitis using objective parameters. We compared the epidermal hydration and the skin surface lipids, the so-called hydro-lipid film, of the clinically unaffected skin of patients suffering from atopic dermatitis with that of healthy subjects.
A total of 48 patients of either gender were included in this retrospective case-control study. We used the Corneometer CM 820 (Courage+Khazaka Electronic GmbH, Cologne, Germany) and the Sebumeter SM 810 (Courage+Khazaka Electronic GmbH) as noninvasive measuring methods.
The results showed marked decreases in the atopic dermatitis group for both the Corneometer and Sebumeter measuring methods.
Our results show that the dry skin of patients with atopic dermatitis, as previously shown, is due not only to a decrease in skin moisture but also to a reduction of skin lipids. This finding gives rise to a new understanding of the condition, and therefore one should always speak of a hydro-lipid film.
Epinastine is a potent antiallergic agent that has not only antihistaminic (H(1)) properties but also provides antileukotriene, anti-PAF and antibradykinin activities, which are associated with its antiallergic actions. Moreover, epinastine is very effective in inhibiting the release of chemical mediators from mast cells exposed to antigen. In addition, IL-8 release from eosinophils was inhibited by epinastine posttranscriptionally. Chemotatic movement of eosinophils was also blocked by epinastine. The increase in EEG power spectrum at low frequency region detected at frontal cortex is associated with drowsiness. No such change was induced by epinastine, while a marked increase was observed after ketotifen. In agreement with this, when the amount of H(1) blockers that penetrated through the BBB into the brain was estimated by means of PET, it was apparent that epinastine hardly penetrated the BBB. With regard to the current-voltage relationship of HERG currents, epinastine did not affect I(Kr), while a marked inhibition was seen after terfenadine or astemizole. These results indicated that epinastine does not suppress delayed rectifier potassium current of the heart and, consequently, no cardiotoxic action of epinastine was postulated. In man, epinastine is readily absorbed after oral administration and no significant change in pharmacokinetics was found during chronic administration. In teratological studies in rats, malformation and variation were not observed even at high doses of epinastine. In the clinical application of epinastine, it was shown that this drug is remarkably effective in the treatment of various dermatological diseases, such as chronic urticaria, psoriasis vulgaris and other pruritic dermatoses. Moreover, epinastine provides excellent clinical efficacy in the treatment of allergic rhinitis. Although efficacy of H(1) blockers in bronchial asthma is somewhat doubtful, the overall improvement rate in asthmatic patients was significantly higher in epinastine-treated patients (53.7%) compared to those treated with ketotifen (25%).
Atopic dermatitis (AD) is a chronic allergic inflammatory disease, which manifests itself with eczematous skin lesions.
We compared the clinical efficacy of tacrolimus ointment (0.1%) given twice a day and oral cyclosporine (3 mg/kg) given once daily. Rescue medication for itching included cetirizine 10-20 mg (equal to one or two tables).
Thirty patients, aged 13-45 years (mean+/-SD 27.1+/-10.9), with a history of moderate-to-severe AD were randomized to treatments, 15 patients for each treatments. Assessment of efficacy was based on SCORAD, on scores of daily itching, erythema, interference with sleep, due to the skin condition and days without use of cetirizine tablets. SCORAD, measured on a scale (0-103), was evaluated before treatment (0) and at 7, 14, 21, 28, 35 and 42 days after treatment. Similarly, the means of daily symptoms, on a scale (0-3), were evaluated before the treatment (0) and at 7, 14, 21, 28, 35 and 42 days after treatment; finally, on day without use of cetirizine tablets. The safety of the study treatments was assessed through haematologic, biochemical and urinary testing and on systolic and diastolic blood pressures and heart rate measurements.
SCORAD decreased in the two treatment groups 14 days after the beginning of the period study. However, the patients in tacrolimus ointment group reported significantly lower SCORAD than those treated with oral cyclosporine. Overall SCORAD, as assessed by the area under the curve (AUC) day(0-42) (score/day), was significantly lower in the tacrolimus ointment group when compared with oral cyclosporine (P<0.001). Similarly, AUC day(0-42) (score/day) for itching, erythema and number of nights without interference with the sleep due to skin condition were significantly lower in the group of patients treated with tacrolimus compared with those treated with cyclosporine (P=0.003, 0.005 and 0.01, respectively). As regards the use of rescue medication, expressed by median of number of days without use of anti-H(1), it was significantly lower in the group treated with tacrolimus (82.5) than in the cyclosporine group (76.5) (P=0.03). There were no appreciable changes in haematological and biochemical indices, in both treatments groups.
The results of this comparative study demonstrate that tacrolimus ointment twice daily and cyclosporine administered orally once daily are effective on SCORAD, daily symptoms and anti-H(1) rescue. When we compared tacrolimus and cyclosporine there was a faster onset of action in the group treated with tacrolimus. The two drugs presented the same safety. However, these data support the preferential use of topical tacrolimus 0.1% in AD, because cyclosporine has potential side-effects.
Beijing : People's Medical Publishing House
- H J Tao
- Bencaojingjizhu
Tao HJ. Bencaojingjizhu. Beijing : People's Medical
Publishing House. 1994 : 416.
Effect of herb extracts mixed with Houttuynia Cordata on antiatopic dermatitis in DNCB-induced BALB/c mouse
- S O Park
- B S Park
- C M Ryu
- Y S Ahn
Park SO, Park BS, Ryu CM, Ahn YS. Effect of
herb extracts mixed with Houttuynia Cordata on
antiatopic dermatitis in DNCB-induced BALB/c mouse.
J Kor Oil Chemists Soc. 2012 ; 2 : 175-83.
Study on the development of cosmetic emulsion cream for patients with atopic dermatitis using Scutellaria Baicalensis
- C I Park
Park CI. Study on the development of cosmetic
emulsion cream for patients with atopic dermatitis
using Scutellaria Baicalensis. Kor J Herbology.
2006 ; 21 : 47-53.
Effect of Kamichungdieum on immune reaction
- J S Eun
- D H Lee
- Y K Jeon
- Y A Kwon
- J Kwon
Eun JS, Lee DH, Jeon YK, Kwon YA, Kwon J.
Effect of Kamichungdieum on immune reaction. Kor
J Orient Physiol Pathology. 2003 ; 18 : 1391-6.
Effect of Hwangryunhaedok-tang extracts on DNCB-induced allergic contact dermatitis
- B A Kim
- J C Yang
- C I Park
Kim BA, Yang JC, Park CI. Effect of
Hwangryunhaedok-tang extracts on DNCB-induced
allergic contact dermatitis. Kor J Herbology. 200
9； 24： 1-5.
Beijing : People's Medical Publishing House
- S Z Li
- Bencaogangmu
Li SZ. Bencaogangmu. Beijing : People's Medical
Publishing House. 1982 : 2769.